6 completed. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 1 | Completed 1 |
Follow Affective Disorders, Psychotic: new trials by email Literature Review of Affective Disorders, Psychotic trials Research Report on Affective Disorders, Psychotic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Smoking Cessation for Veterans With Severe and Persistent Mental Illness BTSCS, StSST - Schizoaffective Disorder, Schizophrenia | Phase 2 / Phase 3 | Completed | US Department of Veterans Affairs | 179 | 2010-04-01 | 2015-08-18 |
| A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder Placebo, Quetiapine, Paliperidone ER - Bipolar Disorder, Mood Disorders | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 493 | 2006-04-01 | 2014-06-20 |
| A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder Paliperidone ER - Affective Psychosis, Bipolar, Bipolar Disorder | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 300 | 2006-04-01 | 2011-05-18 |
| A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder Paliperidone extended-release - Bipolar Disorder, Mood Disorders | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 473 | 2006-02-01 | 2011-06-09 |
| A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder Topiramate, Placebo - Bipolar Disorder, Affective Disorders, Psychotic | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 13 | 2002-01-01 | 2011-06-27 |
| A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder topiramate - Bipolar Disorders, Mood Disorders | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 363 | 2000-10-01 | 2011-06-08 |
Bipolar Disorder (6) · Mania (5) · Mood Disorders (4) · Psychotic Disorders (2) · Depression (1) · Mental Disorders (1) · Schizophrenia (1) · Smoking Cessation (1)
Bipolar and Related Disorders (6) · Schizophrenia Spectrum and Other Psychotic Disorders (6) · Mental Disorders (5) · Nervous System Diseases (5) · Neurobehavioral Manifestations (5) · Neurologic Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Behavior (2) · Mood Disorders (2) · Behavioral Symptoms (1) · Health Behavior (1)
Paliperidone Palmitate (2) · Topiramate (2) · Quetiapine Fumarate (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (5) · US Department of Veterans Affairs (1)
United States (2) · Greece (1) · Lithuania (1) · Russia (1) · South Korea (1) · Taiwan (1) · Turkey (Türkiye) (1) · Ukraine (1)